{"title":"Biopiezoelectric-based nanomaterials; a promising strategy in cancer therapy.","authors":"Tingting Zuo, Saikat Dewanjee, Chao Zhang, Pratik Chakraborty, Wanxia Lu, Niraj Kumar Jha, Hiranmoy Bhattacharya, Moumita Gangopadhyay, Joshua Fleishman, Saurabh Kumar Jha, Zhe-Sheng Chen","doi":"10.1186/s13046-025-03427-2","DOIUrl":null,"url":null,"abstract":"<p><p>Cancer is one of the deadliest diseases, continually prompting physicians and researchers to investigate safe and effective modalities for its treatment. Piezoelectric nanomaterial is a new class of material with enormous potential for the nanoscale and bidirectional conversion of mechanical strain into electric fields for cancer treatment. In response to ultrasound mechanical strain, a piezopotential and electric field is generated in the tumor microenvironment, which reduces the growth of cancer cells by catalyzing redox reactions and the synthesis of reactive oxygen species. In this review, we discuss the basic concepts and mechanisms of biopiezoelectric nanomaterials as anti-cancer agents. We provide a comprehensive summary of current state-of-the-art piezoelectric nanoparticles as anti-cancer therapies. Lastly, we identify current challenges that must be addressed for the proper clinical development of biopiezoelectric nanomaterial-based anti-cancer agents and provide future perspectives for the development of this technology.</p>","PeriodicalId":50199,"journal":{"name":"Journal of Experimental & Clinical Cancer Research","volume":"44 1","pages":"171"},"PeriodicalIF":11.4000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Experimental & Clinical Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13046-025-03427-2","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Cancer is one of the deadliest diseases, continually prompting physicians and researchers to investigate safe and effective modalities for its treatment. Piezoelectric nanomaterial is a new class of material with enormous potential for the nanoscale and bidirectional conversion of mechanical strain into electric fields for cancer treatment. In response to ultrasound mechanical strain, a piezopotential and electric field is generated in the tumor microenvironment, which reduces the growth of cancer cells by catalyzing redox reactions and the synthesis of reactive oxygen species. In this review, we discuss the basic concepts and mechanisms of biopiezoelectric nanomaterials as anti-cancer agents. We provide a comprehensive summary of current state-of-the-art piezoelectric nanoparticles as anti-cancer therapies. Lastly, we identify current challenges that must be addressed for the proper clinical development of biopiezoelectric nanomaterial-based anti-cancer agents and provide future perspectives for the development of this technology.
期刊介绍:
The Journal of Experimental & Clinical Cancer Research is an esteemed peer-reviewed publication that focuses on cancer research, encompassing everything from fundamental discoveries to practical applications.
We welcome submissions that showcase groundbreaking advancements in the field of cancer research, especially those that bridge the gap between laboratory findings and clinical implementation. Our goal is to foster a deeper understanding of cancer, improve prevention and detection strategies, facilitate accurate diagnosis, and enhance treatment options.
We are particularly interested in manuscripts that shed light on the mechanisms behind the development and progression of cancer, including metastasis. Additionally, we encourage submissions that explore molecular alterations or biomarkers that can help predict the efficacy of different treatments or identify drug resistance. Translational research related to targeted therapies, personalized medicine, tumor immunotherapy, and innovative approaches applicable to clinical investigations are also of great interest to us.
We provide a platform for the dissemination of large-scale molecular characterizations of human tumors and encourage researchers to share their insights, discoveries, and methodologies with the wider scientific community.
By publishing high-quality research articles, reviews, and commentaries, the Journal of Experimental & Clinical Cancer Research strives to contribute to the continuous improvement of cancer care and make a meaningful impact on patients' lives.